OncoSec Medical (ONMA) Financial Statements
OncoSec Medical Financial Overview
OncoSec Medical's market cap is currently $5. The company's EPS TTM is $-277.75; its P/E ratio is 0.00; OncoSec Medical is scheduled to report earnings on June 15, 2023, and the estimated EPS forecast is $-14.83. See an overview of income statement, balance sheet, and cash flow financials.
| Jul 22 | Jul 21 | Jul 20 | Jul 19 | Jul 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -1.07M | $ -1.08M | $ -990.29K | $ -243.71K | $ 0.00 |
| Operating Income | $ -37.01M | $ -48.38M | $ -43.41M | $ -30.42M | $ -36.11M |
| EBITDA | $ -36.43M | $ -46.49M | $ -42.23M | $ -30.03M | $ -32.43M |
| Net Income | $ -34.18M | $ -45.17M | $ -42.25M | $ -30.28M | $ -39.14M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 12.30M | $ 45.95M | $ 20.35M | $ 25.15M | $ 26.98M |
| Total Assets | $ 21.88M | $ 56.28M | $ 29.90M | $ 29.89M | $ 30.25M |
| Total Debt | $ 6.17M | $ 7.32M | $ 7.82M | $ 83.76K | $ 0.00 |
| Net Debt | $ -6.12M | $ -38.63M | $ -12.53M | $ -25.06M | $ -3.80M |
| Total Liabilities | $ 15.76M | $ 18.20M | $ 16.03M | $ 5.61M | $ 7.32M |
| Stockholders' Equity | $ 6.12M | $ 38.08M | $ 13.87M | $ 24.28M | $ 22.92M |
| Cash Flow | |||||
| Free Cash Flow | $ -32.38M | $ -42.59M | $ -33.15M | $ -29.01M | $ -23.29M |
| Operating Cash Flow | $ -32.14M | $ -41.79M | $ -33.15M | $ -29.00M | $ -23.22M |
| Investing Cash Flow | $ -244.86K | $ -799.60K | $ 0.00 | $ 23.20M | $ -23.29M |
| Financing Cash Flow | $ -1.16M | $ 68.21M | $ 28.40M | $ 27.20M | $ 38.88M |
Currency in USD